Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women

计划入组 30 人 · 首次发布于 2016 年 11 月 18 日

Testosterone in Female Hypoactive Sexual Desire Disorder

计划入组 20 人 · 首次发布于 2005 年 9 月 1 日

Hypoactive Sexual Desire Disorder in Males

计划入组 8 人 · 首次发布于 2019 年 6 月 28 日

Flibanserin(Addyi)

C₂₀H₂₁F₃N₄O · Rx

ALTO-102 + ALTO-103 + ALTO-104

PS-778629

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

The Princess Alexandra Hospital NHS Trust

United Kingdom

BLACKPOOL TEACHING HOSPITALS NHS FOUNDATION TRUST

United Kingdom

FDA Approves Expanded Flibanserin Indication for Postmenopausal Women with Hypoactive Sexual Desire Disorder

Study Finds Women With Hypoactive Sexual Desire Disorder Still Engage in 'Mercy Sex' Two to Three Times Monthly

FDA Approves Addyi: First Pill to Combat Low Libido in Women